
$8.2B+38% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $8.2B in 2025, compounding +11% a year since 2022 though the pace has cooled. The trailing twelve months are already running at $9.5B, ahead of the last full year.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
$2.7BFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Net income was $2.7B in 2025, against $-164M the year before.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
+38.4%revenue growth, FY 2025
→Revenue grew +38% in 2025 against a five-year average of +40%.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
$1.4B+29% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Free cash flow was $1.4B in 2025, compounding +9% a year since 2022. That is the most cash the business has ever thrown off in a year. The trailing twelve months stand at $1.7B.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
→Of $8.2B in 2025 sales, $2.7B reaches net profit - 33 cents on the dollar. The largest single deduction is producing the product ($4.0B).
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→17 cents of every sales dollar became free cash in 2025, and it has held steady since 2022.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
◌ 2026 = trailing twelve months to the latest filed quarter (2026-08-01), not a full fiscal year
→The biggest claim on each sales dollar is research and development, at 25% of revenue (stock compensation 7%, capital spending 4%). That share has fallen since 2022, so the cost of competing is easing.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
◌ 2026 = trailing twelve months to the latest filed quarter (2026-08-01), not a full fiscal year
→Operating margin widened 12 points to 16% since 2022. After everything, 33 cents of each sales dollar reaches net profit.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
◌ 2026 = trailing twelve months to the latest filed quarter (2026-08-01), not a full fiscal year
→ROE of 14% sits well above ROCE of 7%. A meaningful share of the shareholder return is manufactured with leverage rather than operations.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
73.6xP/E today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At 20.7x sales, the market is paying +153% more than MRVL's own 4-year median of 8.2x. Expectations are elevated, so more has to go right to justify the price.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
0.9%FCF yield today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→Every dollar of market value currently buys 0.9% of annual free cash flow, less than its 4-year median of 2.5% - you are paying up for the same cash.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
→Debt of $5.0B sits against $3.9B of cash, or 0.3x shareholders' equity. Earnings cover interest 7.6 times - adequate, with less room than it looks in a downturn.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
→The company's own capital grew from $14.8B in 2023 to $18.5B (+25%). The business is building book value rather than consuming it.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
→Shareholders received $2.0B in buybacks and $205M in dividends in 2025. Stock compensation issued $591M of new shares in the same year, offsetting 26% of that.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
→The share count grew 2.1% in 2025, averaging 9.4% a year over three years. Your slice of the company shrinks by that much each year unless earnings grow faster.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
→The dividend per share reached $0.24 in 2025, compounding -0% a year since 2020.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
→MRVL earns 6.9% on the capital it employs, below the 10% most investors treat as the cost of capital. It was 1.2% in 2022, so the trend is up. That is the highest in MRVL's filed history.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
→MRVL issued +30% more shares from 2020 to 2025, but revenue per share still rose +112%. The dilution bought more growth than it cost existing holders.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01
→Insiders sold $32M on the open market and bought nothing. Many sales are pre-scheduled diversification rather than a view on the price. A further 50 filings were grants, option exercises or tax withholding, which say nothing either way.
Source: SEC EDGAR (XBRL company facts) · as at 2026-08-01